Passive immunization against the MHC class I molecule Mamu-AG disrupts rhesus placental development and endometrial responses

Journal of Immunology

Volumn 179, Issue 12, 2007, Pages 8042-8050

  Bondarenko, Gennadiy I ^a   Burleigh, David W ^a,c   Durning, Maureen ^a   Breburda, Edith E ^a   Grendell, Richard L ^a   Golos, Thaddeus G ^a,b  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c RICHARD STOCKTON COLLEGE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAMU AG; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 1; MAMU I ANTIGEN; MAMU-I ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; FETAL WELL BEING; GROWTH REGULATION; IMMUNOLOGICAL TOLERANCE; IMPLANTATION; IN VIVO STUDY; LEUKOCYTE; MICROVASCULARIZATION; MOTHER FETUS RELATIONSHIP; NIDATION; NONHUMAN; PASSIVE IMMUNIZATION; PLACENTA; PLACENTA DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHESUS MONKEY; STROMA CELL; TROPHOBLAST; UTERINE BLOOD VESSEL; ANIMAL; CYTOLOGY; DECIDUA; IMMUNOLOGY; MACACA; REPRODUCTION; VASCULARIZATION;

ANIMALS; DECIDUA; ENDOMETRIUM; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNIZATION, PASSIVE; LEUKOCYTES; MACACA MULATTA; PLACENTA; PLACENTATION; PREGNANCY; STROMAL CELLS;

EID: 40049088848     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.12.8042     Document Type: Article

References (52)

1. McMaster, M. T., C. L. Librach, Y. Zhou, K. H. Lim, M. J. Janatpour, R. DeMars, S. Kovats, C. Damsky, and S. J. Fisher. 1995. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J. Immunol. 154: 3771-3778.
2. Hunt, J. S. 2006. Stranger in a strange land. Immunol. Rev. 213: 36-47.
3. Blaschitz, A., H. Hutter, and G. Dohr. 2001. HLA class I protein expression in the human placenta. Early Pregnancy 5: 67-69.
4. Clements, C. S., L. Kjer-Nielsen, L. Kostenko, H. L. Hoare, M. A. Dunstone, E. Moses, K. Freed, A. G. Brooks, J. Rossjohn, and J. McCluskey. 2005. Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface. Proc. Natl. Acad. Sci. USA 102: 3360-3365.
5. Sanders, S. K., P. A. Giblin, and P. Kavathas. 1991. Cell-cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class I molecule on cytotrophoblasts. J. Exp. Med. 174: 737-740.
6. Lee, N., A. R. Malacko, A. Ishitani, M. C. Chen, J. Bajorath, H. Marquardt, and D. E. Geraghty. 1995. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3: 591-600.
7. Diehl, M., C. Munz, W. Keilholz, S. Stevanovic, N. Holmes, Y. W. Loke, and H. G. Rammensee. 1996. Nonclassical HLA-G molecules are classical peptide presenters. Curr. Biol. 6: 305-314.
8. Colonna, M., H. Nakajima, F. Navarro, and M. Lopez-Botet. 1999. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J. Leukocyte Biol. 66: 375-381.
9. Navarro, F., M. Llano, T. Bellon, M. Colonna, D. E. Geraghty, and M. Lopez-Botet. 1999. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 29: 277-283.
10. Shiroishi, M., K. Tsumoto, K. Amano, Y. Shirakihara, M. Colonna, V. M. Braud, D. S. Allan, A. Makadzange, S. Rowland-Jones, B. Willcox, et al. 2003. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA 100: 8856-8861.
11. Rajagopalan, S., Y. T. Bryceson, S. P. Kuppusamy, D. E. Geraghty, A. van der Meer, I. Joosten, and E. O. Long. 2006. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PloS Biol. 4: e9.
12. + cells by interacting with CD8. J. Immunol. 164: 6100-6104.
13. Fons, P., S. Chabot, J. E. Cartwright, F. Lenfant, F. L'Faqihi, J. Giustiniani, J. P. Herault, G. Gueguen, F. Bono, P. Savi, et al. 2006. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 108: 2608-2615.
14. Le Bouteiller, P., N. Pizzato, A. Barakonyi, and C. Solier. 2003. HLA-G, pre-eclampsia, immunity and vascular events. J. Reprod. Immunol. 59: 219-234.
15. Watkins, D. I. 1995. The evolution of major histocompatibility class I genes in primates. Crit. Rev. Immunol. 15: 1-29.
16. Adams, E. J., and P. Parham. 2001. Species-specific evolution of MHC class I genes in the higher primates. Immunol. Rev. 183: 41-64.
17. Boyson, J. E., K. K. Iwanaga, T. G. Golos, and D. I. Watkins. 1996. Identification of the rhesus monkey HLA-G ortholog: mamu-G is a pseudogene. J. Immunol. 157: 5428-5437.
18. Arnaiz-Villena, A., P. Morales, E. Gomez-Casado, M. J. Castro, P. Varela, R. Rojo-Amigo, and J. Martinez-Laso. 1999. Evolution of MHC-G in primates: a different kind of molecule for each group of species. J. Reprod. Immunol. 43: 111-125.
19. Boyson, J. E., K. K. Iwanaga, T. G. Golos, and D. I. Watkins. 1997. Identification of a novel MHC class I gene: mamu-AG, expressed in the placenta of a primate with an inactivated G locus. J. Immunol. 159: 3311-3321.
20. Ryan, A. F., R. L. Grendell, D. E. Geraghty, and T. G. Golos. 2002. A soluble isoform of the rhesus monkey nonclassical MHC class I molecule mamu-AG is expressed in the placenta and the testis. J. Immunol. 169: 673-683.
21. Slukvin, I. I., J. E. Boyson, D. I. Watkins, and T. G. Golos. 1998. The rhesus monkey analogue of human lymphocyte antigen-G is expressed primarily in villous syncytiotrophoblast. Biol. Reprod. 58: 728-738.
22. Slukvin, I. I., D. I. Watkins, and T. G. Golos. 1999. Tissue distribution of the mRNA for a rhesus monkey major histocompatibility class Ib molecule, mamu-AG. Tissue Antigens 53: 282-291.
23. Slukvin, I. I., D. P. Lunn, D. I. Watkins, and T. G. Golos. 2000. Placental expression of the nonclassical MHC class I molecule Mamu-AG at implantation in the rhesus monkey. Proc. Natl. Acad. Sci. USA 97: 9104-9109.
24. Baddeley, A. J., H. J. Gundersen, and L. M. Cruz-Orive. 1986. Estimation of surface area from vertical sections. J. Microsc. 142: 259-276.
25. Maly, A., G. Goshen, J. Sela, A. Pinelis, M. Stark, and B. Maly. 2005. Histomorphometric study of placental villi vascular volume in toxemia and diabetes. Hum. Pathol. 36: 1074-1079.
26. Willemse, F., M. Nap, H. W. de Bruijn, and H. Hollema. 1997. Quantification of vascular density and of lumen and vessel morphology in endometrial carcinoma: evaluation of their relation to serum levels of tissue polypeptide-specific antigen and CA-125. Anal. Quant. Cytol. Histol. 19: 1-7.
27. Benirschke, K., and P. Kaufmann. 2000. The Pathology of the Human Placenta, 4th Ed. Springer-Verlag, New York.
28. Chen, C. P., R. Bajoria, and J. D. Aplin. 2002. Decreased vascularization and cell proliferation in placentas of intrauterine growth-restricted fetuses with abnormal umbilical artery flow velocity waveforms. Am. J. Obstet. Gynecol. 187: 764-769.
29. Mayhew, T. M., C. Ohadike, P. N. Baker, I. P. Crocker, C. Mitchell, and S. S. Ong. 2003. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta 24: 219-226.
30. King, B. F., and J. J. Mais. 1982. Developmental changes in rhesus monkey placental villi and cell columns: scanning electron microscopy. Anat. Embryol. 165: 361-376.
31. Enders, A. C. 1989. Trophoblast differentiation during the transition from trophoblastic plate to lacunar stage of implantation in the rhesus monkey and human. Am. J. Anat. 186: 85-98.
32. Blankenship, T. N., and A. C. Enders. 1997. Trophoblast cell-mediated modifications to uterine spiral arteries during early gestation in the macaque. Acta Anat. 158: 227-236.
33. Enders, A. C., A. O. Welsh, and S. Schlafke. 1985. Implantation in the rhesus monkey: endometrial response. Am. J. Anat. 173: 147-169.
34. Lau, D., A. Seibert, D. Gandara, L. Laptalo, E. Geraghty, and C. Coulon. 2005. Computer-assisted image analysis bronchioloalveolar carcinoma. Clin. Lung Cancer. 6: 281-286.
35. Breburda, E. E., S. V. Dambaeva, I. I. Slukvin, and T. G. Golos. 2006. Selective distribution and pregnancy-specific expression of DC-SIGN at the maternal-fetal interface in the rhesus macaque: DC-SIGN is a putative marker of the recognition of pregnancy. Placenta 27: 11-21.
36. Babischkin, J. S., D. W. Burleigh, T. M. Mayhew, G. J. Pepe, and E. D. Albrecht. 2001. Developmental regulation of morphological differentiation of placental villous trophoblast in the baboon. Placenta 22: 276-283.
37. Slukvin, I. I., E. E. Breburda, and T. G. Golos. 2004. Dynamic changes in primate endometrial leukocyte populations: differential distribution of macrophages and natural killer cells at the rhesus monkey implantation site and in early pregnancy. Placenta 25: 297-307.
38. Tabiasco, J., M. Rabot, M. Aguerre-Girr, H. El Costa, A. Berrebi, O. Parant, G. Laskarin, K. Juretic, A. Bensussan, D. Rukavina, and P. Le Bouteiller. 2006. Human decidual NK cells: unique phenotype and functional properties, a review. Placenta 27 (Suppl. A): S34-S39.
39. Slukvin, I. I., D. I. Watkins, and T. G. Golos. 2001. Phenotypic and functional characterization of rhesus monkey decidual lymphocytes: rhesus decidual large granular lymphocytes express CD56 and have cytolitic activity. J. Reprod. Immunol. 50: 57-79.
40. Koopman, L. A., H. D. Kopcow, B. Rybalov, J. E. Boyson, J. S. Orange, F. Schatz, R. Masch, C. J. Lockwood, A. D. Schachter, P. J. Park, and J. L. Strominger. 2003. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 198: 1201-1212.
41. Hanna, J., D. Goldman-Wohl, Y. Hamani, I. Avraham, C. Greenfield, S. Natanson-Yaron, D. Prus, L. Cohen-Daniel, T. I. Arnon, I. Manaster, et al. 2006. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 12: 1065-1074.
42. Lash, G. E., B. Schiessl, M. Kirkley, B. A. Innes, A. Cooper, R. F. Searle, S. C. Robson, and J. N. Bulmer. 2006. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J. Leukocyte Biol. 80: 572-580.
43. Goldman-Wohl, D. S., I. Ariel, C. Greenfield, D. Hochner-Celnikier, J. Cross, S. Fisher, and S. Yagel. 2000. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol. Hum. Reprod. 6: 88-95.
44. Vince, G. S., and P. M. Johnson. 2000. Leucocyte populations and cytokine regulation in human uteroplacental tissues. Biochem. Soc. Trans. 28: 191-195.
45. Harris, L. K., R. J. Keogh, M. Wareing, P. N. Baker, J. E. Cartwright, J. D. Aplin, and G. S. Whitley. 2006. Invasive trophoblasts stimulate vascular smooth muscle cell apoptosis by a fas ligand-dependent mechanism. Am. J. Pathol. 169: 1863-1874.
46. Bahri, R., F. Hirsch, A. Josse, N. Rouas-Freiss, N. Bidere, A. Vasquez, E. D. Carosella, B. Charpentier, and A. Durrbach. 2006. Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes. J. Immunol. 176: 1331-1339.
47. Red-Horse, K., J. Rivera, A. Schanz, Y. Zhou, V. Winn, M. Kapidzic, E. Maltepe, K. Okazaki, R. Kochman, K. C. Vo, et al. 2006. Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentation. J. Clin. Invest. 116: 2643-2652.
48. Imanishi, T., D. K. Han, L. Hofstra, T. Hano, I. Nishio, W. C. Liles, A. M. Gown, and S. M. Schwartz. 2002. Apoptosis of vascular smooth muscle cells is induced by Fas ligand derived from monocytes/macrophage. Atherosclerosis 161: 143-151.
49. McIntire, R. H., P. J. Morales, M. G. Petroff, M. Colonna, and J. S. Hunt. 2004. Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-β1. J. Leukocyte Biol. 76: 1220-1228.
50. Ashkar, A. A., J. P. Di Santo, and B. A. Croy. 2000. Interferon γ contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J. Exp. Med. 192: 259-270.
51. Fazleabas, A. T., J. J. Kim, and Z. Strakova. 2004. Implantation: embryonic signals and the modulation of the uterine environment: a review. Placenta 25 (Suppl. A): S26-S31.
52. Matteri, R. L., J. F. Roser, D. M. Baldwin, V. Lipovetsky, and H. Papkoff. 1987. Characterization of a monoclonal antibody which detects luteinizing hormone from diverse mammalian species. Domest. Anim. Endocrinol. 4: 157-165.